The effect of remimazolam, a new anesthetic, on hemodynamics

JRCT ID: jRCT1011210077

Registered date:22/03/2022

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Non-cardiac surgery
• Date of first enrollment: 18/03/2022
• Target sample size: 24
• Study type: Interventional
• Intervention(s): Induction of general anesthesia with arterial line

Outcome(s)

• Primary Outcome: dPmx
• Secondary Outcome: Heart rate, mean arterial pressure, stroke volume, cardiac output, caridac index, cardiac power output, cardiac power index, systemic vascular resistance, systemic vascular resistance index, stroke volume variation, pulse pressure variation, BIS

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Patients receiving non-cardiac surgery under general anesthesia with arterial line (ASA physical status I or II)
• Exclude criteria: Severe heart valve disease, ischemic heart disease, arrhythmia, expected difficult airway, allergy against propofol or remimazolam, acute angle closure glaucoma, myasthenia gravis

Related Information

• Primary Sponsor: Edanaga Mitsutaka